Nordic Business Report-April 20, 2006-IDL Biotech AB reports Q1 operating loss of SEK0.32m
(C)1994-2006 M2 COMMUNICATIONS LTD http://www.m2.com
The Swedish diagnostic laboratory tests developer IDL Biotech AB issued on Thursday (20 April) its interim report for the first quarter, posting an operating loss of SEK0.32m, as compared to a loss of SEK0.21m in the first quarter of 2005.
The net turnover amounted to SEK2.68m, as compared to SEK2.63m in the first quarter last year.
One Swedish krona (SEK) is worth approximately 0.07 British pounds (GBP).
((Comments on this story may be sent to firstname.lastname@example.org))